If you have questions, please contact Dexcom CARE®, our team of certified diabetes educators and other healthcare professionals, at 877-339-2664 (ext.4950) or [email protected]; your local sales rep; or visit hcp.dexcom.com.

Dexcom does not provide dosing guidance for HCPs. There are, however, three approaches to using the rate-of-change arrows for adjusting insulin doses. These are:

1. DirecNet Method

* Use of the DirecNet Applied Treatment Algorithm (DATA) for Diabetes Management with a Real-Time Continuous Glucose Monitor (the FreeStyle Navigator). Pediatr Diabetes. 2008 Apr; 9(2):142-147.

2. Jeremy Pettus and Steven Edelman Method

* Recommendations for using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes. Journal Diabetes Science and Technology. August 2016.

3. Gary Scheiner Method

* Practical CGM: Guide to Improving Outcomes Through Continuous Glucose Monitoring. American Diabetes Association, 2015.

Once a patient has been added to the Patient list, click the patient name to invite them to share their data or choose to upload receiver data. Once sharing has initiated or receiver uploaded, click the patients name, then click Go to interative reports.

Dexcom Clarity follows industry security standards and password expirations are a best practice. You can change your clinic user password when prompted or at anytime from Settings at the top of the page.

• Overview - presents up to four clinically relevant patterns, dashboard statistics as well as the patient’s Best Day. This quick summary can help focus the discussion on problem areas contributing to hyper- and hypoglycemia. When printed, this one page summary contains all information for billing 95251* - a CPT code covered by most insurance carriers.
• Patterns - dive deeper into each of the four clinically relevant patterns. Each pattern provides graphs of the days that contribute to that pattern.
• Data - Trends and Overlay graphs show aggregate data with filtering options. Daily graphs are a detailed view of every glucose data point for each day selected.
• Compare - report provides side-by-side comparison of Trends, Overlay and Daily graphs to encourage progress and highlight challenges patients may face.
• Statistics - provides focused insight for both daily and hourly glucose metrics. Advanced metrics can be selected for deeper analytics.
• AGP - standardized Ambulatory Glucose Profile (AGP) report provides a big picture view of diabetes management.

The Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System is the latest professional CGM system created by Dexcom for healthcare providers (HCPs). Dexcom G6 Pro is factory-calibrated—zero fingersticks are required.* Dexcom G6 Pro features a one-touch auto-applicator and a single-use, disposable transmitter that auto-starts. The Dexcom G6 Pro CGM System is comprised of a sensor, transmitter, and (if used in unblinded mode) a patient’s compatible smart device.^† In unblinded mode, Dexcom G6 Pro sends glucose readings to a patient’s compatible smart device every five minutes. Dexcom G6 Pro is indicated for patients ages 2 years and older.

*If your glucose alerts and readings from Dexcom G6 Pro do not match symptoms or expectations (when used in unblinded mode), use a blood glucose meter to make diabetes treatment decisions.

†Patient must have a compatible smart phone for an unblinded mode session. To view a list of compatible devices, visit dexcom.com/compatibility

Dexcom does not currently anticipate any interruptions to our production abilities or capacities. However, we do anticipate delays in the near term related to our customer service and technical support, which means that patients should expect longer wait times on the phone. We appreciate your patients’ understanding and patience during this time.

Dexcom is still accepting orders for products and supplies at this time and does not currently anticipate any interruptions to our ability to produce and supply product, as a result of the coronavirus. However, to ensure supply continuity for all customers, we won’t be processing additional orders for supplies outside of what is covered by a patient’s insurance at this time.

At Dexcom, we consider patient safety our number one priority. With the recent news of the impact COVID-19 is having across the US, we are aligned with community actions that will prevent the spread of the virus and have made the decision to have our field-based employees work from home. We will only allow our employees to enter your facility once it is determined safe to do so. In the meantime, diabetes will continue, and we want to make sure that you have all of the information you need to treat this at-risk population successfully. Our field and all supporting partners will be available via email, telephone, and video meetings to help you meet the needs of your patients with diabetes.

No. While the State of California recently issued a stay-at-home order requiring non-essential businesses to close until further notice, the order does not apply to companies performing “essential” services or functions like Dexcom.